Journal of Surgery Concepts & Practice ›› 2022, Vol. 27 ›› Issue (03): 276-280.doi: 10.16139/j.1007-9610.2022.03.019
• Review • Previous Articles
CHEN Chengkun, GUO Bomin, DENG Xianzhao, WU Bo, FAN Youben()
Received:
2020-09-14
Online:
2022-06-25
Published:
2022-08-03
Contact:
FAN Youben
E-mail:fanyouben2006@163.com
CLC Number:
CHEN Chengkun, GUO Bomin, DENG Xianzhao, WU Bo, FAN Youben. Diagnosis and treatment of medullary thyroid carcinoma-an update[J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 276-280.
[1] |
Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6):567-610.
doi: 10.1089/thy.2014.0335 URL |
[2] |
Mathiesen JS, Kroustrup JP, Vestergaard P, et al. Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study[J]. Endocr Connect, 2018, 7(6):829-839.
doi: 10.1530/EC-18-0157 pmid: 29760189 |
[3] |
Torresan F, Mian C, Cavedon E, et al. Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening[J]. Langenbecks Arch Surg, 2019, 404(4):411-419.
doi: 10.1007/s00423-019-01764-3 URL |
[4] |
Kihara M, Miyauchi A, Kudo T, et al. Serum calcitonin reference values for calcium stimulation tests by electrochemiluminescence immunoassay in Japanese men with non-medullary thyroid carcinoma[J]. Surg Today, 2018, 48(2):223-228.
doi: 10.1007/s00595-017-1578-7 URL |
[5] |
Giovanella L, Imperiali M, Piccardo A, et al. Procalcitonin measurement to screen medullary thyroid carcinoma: a prospective evaluation in a series of 2 705 patients with thyroid nodules[J]. Eur J Clin Invest, 2018, 48(6):e12934.
doi: 10.1111/eci.12934 URL |
[6] |
Parmer M, Milan S, Torabi A. Calcitonin-negative neuroendocrine tumor of the thyroid[J]. Int J Surg Pathol, 2017, 25(2):191-194.
doi: 10.1177/1066896916670989 pmid: 27658647 |
[7] |
Liang X, Zhu J, Cai M, et al. Progrp as a novel biomar-ker for the differential diagnosis of medullary thyroid carcinoma in patients with thyroid nodules[J]. Endocr Pract, 2020, 26(5):514-522.
doi: 10.4158/EP-2019-0396 URL |
[8] |
Turkdogan S, Forest VI, Hier MP, et al. Carcinoembryo-nic antigen levels correlated with advanced disease in medullary thyroid cancer[J]. J Otolaryngol Head Neck Surg, 2018, 47(1):55.
doi: 10.1186/s40463-018-0303-x pmid: 30223887 |
[9] |
Parra-Robert M, Orois A, Augé JM, et al. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma[J]. Clin Chem Lab Med, 2017, 55(3):441-446.
doi: 10.1515/cclm-2016-0572 pmid: 27754959 |
[10] |
Maleki Z, Abram M, Dell′Aquila M, et al. Insulinoma-associated protein 1 (INSM-1) expression in medullary thy-roid carcinoma FNA: a multi-institutional study[J]. J Am Soc Cytopathol, 2020, 9(3):185-190.
doi: S2213-2945(20)30032-6 pmid: 32197966 |
[11] |
Suzuki A, Hirokawa M, Takada N, et al. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan[J]. Endocr J, 2017, 64(11):1099-1104.
doi: 10.1507/endocrj.EJ17-0238 pmid: 28883261 |
[12] |
Liu MJ, Liu ZF, Hou YY, et al. Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma[J]. Oncotarget, 2017, 8(16):27520-27528.
doi: 10.18632/oncotarget.15897 URL |
[13] | Wang L, Kou H, Chen W, et al. The diagnostic value of ultrasound in medullary thyroid carcinoma: a comparison with computed tomography[J]. Technol Cancer Res Treat, 2020, 19:1533033820905832. |
[14] | Kushchayev SV, Kushchayeva YS, Tella SH, et al. Medullary thyroid carcinoma: an update on imaging[J]. J Thyroid Res, 2019, 2019:1893047. |
[15] |
Yamaga LYI, Cunha ML, Campos Neto GC, et al. 68Ga-DOTATATE PET/CT in recurrent medullary thyroid carcinoma: a lesion-by-lesion comparison with 111In-octreotide SPECT/CT and conventional imaging[J]. Eur J Nucl Med Mol Imaging, 2017, 44(10):1695-1701.
doi: 10.1007/s00259-017-3701-9 URL |
[16] |
Giovanella L, Treglia G, Iakovou I, et al. EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma[J]. Eur J Nucl Med Mol Imaging, 2020, 47(1):61-77.
doi: 10.1007/s00259-019-04458-6 URL |
[17] |
Zhang X, Yan D, Wang J, et al. Is new American Thyroid Association risk classification for hereditary medullary thyroid carcinoma applicable to Chinese patients? a single-center study[J]. Chin J Cancer Res, 2017, 29(3):223-230.
doi: 10.21147/j.issn.1000-9604.2017.03.08 URL |
[18] |
Elisei R, Bottici V, Cappagli V, et al. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma[J]. Ann Endocrinol (Paris), 2019, 80(3):187-190.
doi: 10.1016/j.ando.2019.04.014 URL |
[19] |
Kihara M, Miyauchi A, Yoshioka K, et al. Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: a single institution experience[J]. Auris Nasus Larynx, 2016, 43(5):551-555.
doi: 10.1016/j.anl.2015.12.016 URL |
[20] |
Mathiesen JS, Kroustrup JP, Vestergaard P, et al. Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997-2013: a nationwide study[J]. Clin Epidemiol, 2019, 11:93-99.
doi: 10.2147/CLEP.S183268 pmid: 30666164 |
[21] |
Essig GF Jr, Porter K, Schneider D, et al. Multifocality in sporadic medullary thyroid carcinoma: an international multicenter study[J]. Thyroid, 2016, 26(11):1563-1572.
doi: 10.1089/thy.2016.0255 URL |
[22] |
de Crea C, Raffaelli M, Milano V, et al. Intraoperative high-dose calcium stimulation test in patients with sporadic medullary thyroid carcinoma is highly accurate in predicting lateral neck metastases[J]. Surgery, 2016, 159(1):70-76.
doi: 10.1016/j.surg.2015.08.022 URL |
[23] |
Filimon S, Payne RJ, Black MJ, et al. Calcitonin secretory index and unsuspected nodal disease in medullary thyroid carcinoma[J]. Endocr Pract, 2018, 24(5):460-467.
doi: 10.4158/EP-2017-0236 pmid: 29847167 |
[24] |
Fan W, Xiao C, Wu F. Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma[J]. J Int Med Res, 2018, 46(5):1982-1989.
doi: 10.1177/0300060518762684 URL |
[25] | Ye L, Zhou X, Lu J, et al. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma[J]. J Clin Lab Anal, 2020, 34(7):e23278. |
[26] |
Wang S, Wang B, Xie C, et al. RET Proto-oncogene gene mutation is related to cervical lymph node metastasis in medullary thyroid carcinoma[J]. Endocr Pathol, 2019, 30(4):297-304.
doi: 10.1007/s12022-019-09588-z URL |
[27] | 史亚飞, 张颖超, 樊友本, 等. 甲状腺髓样癌手术切除范围的研究[J]. 中华普通外科杂志, 2020, 35(11):856-861. |
[28] |
Werner RA, Schmid JS, Higuchi T, et al. Predictive va-lue of 18F-FDG PET in patients with advanced medullary thyroid carcinoma treated with vandetanib[J]. J Nucl Med, 2018, 59(5):756-761.
doi: 10.2967/jnumed.117.199778 URL |
[29] |
Kocsis J, Szekanecz É, Bassam A, et al. First line sorafenib treatment for metastatic medullary thyroid cancer: efficacy and safety analysis[J]. Exp Clin Endocrinol Diabetes, 2019, 127(4):240-246.
doi: 10.1055/s-0044-100378 URL |
[30] | Drilon AE, Subbiah V, Oxnard GR, et al. A phase 1 study of LOXO-292, a potent and highly selective RET inhibitor, in patients with RET-altered cancers[J]. J Clin Oncol, 2018, 36:102. |
[31] |
Gainor JF, Lee DH, Curigliano G, et al. Clinical activity and tolerability of BLU-667, a highly potent and selective RET inhibitor, in patients(pts) with advanced RET-fusion+ non-small cell lung cancer(NSCLC)[J]. J Clin Oncol, 2019, 37:9008.
doi: 10.1200/JCO.2019.37.15_suppl.9008 URL |
[32] |
Meng K, Luo H, Chen H, et al. Prognostic value of numbers of metastatic lymph node in medullary thyroid car-cinoma: a population-based study using the SEER 18 database[J]. Medicine (Baltimore), 2019, 98(1):e13884.
doi: 10.1097/MD.0000000000013884 URL |
[33] | Hassan A, Siddique M, Riaz S, et al. Medullary thyroid carcinoma: prognostic variables and tumour markers affecting survival[J]. J Ayub Med Coll Abbottabad, 2018, 30(Suppl 1)(4):S627-S632. |
[34] |
Trimboli P, Lauretta R, Barnabei A, et al. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma[J]. Int J Biol Markers, 2018, 33(2):156-160.
doi: 10.1177/1724600817747518 URL |
[35] |
Chen L, Sun W, Qian K, et al. High ratio of early postoperative calcitonin to preoperative calcitonin could be a novel indicator of poor prognosis in patients with biochemical incomplete responses in sporadic medullary thyroid cancer[J]. Endocr Pract, 2020, 26(7):738-747.
doi: 10.4158/EP-2019-0404 URL |
[1] | WANG Yuanjiang, ZOU Hao. Clinical study on comprehensive treatment of gallbladder cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 171-176. |
[2] | LIN Han, ZUBAIREGULI Maimaitiabula, SU Tongxuan. Value of heparin-binding protein in diagnosis of bloodstream infection [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(02): 147-153. |
[3] | ZHU Zhenggang. Progress and prospect of surgical comprehensive treatment of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 1-6. |
[4] | ZHAO Fazhi, ZHAO Ping. Formation and improvement of surgery-based treatment system for gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 24-30. |
[5] | ZHANG Jixiang, XIE Zhihua, LI Wei, JIANG Xiaoqing. Classification of intrahepatic cholangiocarcinoma and hot topics in surgical treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 478-482. |
[6] | CHENG Wei, HUANG Yuhua, WANG Jian, LI Yousheng. Multivariate analysis of prognosis of patients with malignant bowel obstruction [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 340-345. |
[7] | LI Rui, LIU Zhuoran, YAN Jiqi. Progress of study on medullary thyroid carcinoma with serum calcitonin-negative and large mass [J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 271-275. |
[8] | WANG Guifu, LIU Renjie, BAI Dousheng, JIANG Guoqing, ZHANG Chi, WANG Qian, WANG Aoqing, JIN Shengjie. Gallstone ileus: diagnosis and treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 169-172. |
[9] | ZHANG Gang, ZHANG Zhe, ZHANG Shu, LI Zhirong, TIAN Wuguo, HUANG Qi, WANG Lingli, XU Yan. Association between RET genotype and disease phenotype in patients with hereditary medullary thyroid carcinoma [J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 522-527. |
[10] | MU Yang, CHEN Xin. Prognotic significance of plasma procalcitonin and C⁃reactive protein in evaluation of multiple trauma patients [J]. Journal of Surgery Concepts & Practice, 2021, 26(06): 532-536. |
[11] | LIN Xiaoyun, QI Luyue, ZHANG Zhenlin, YUE Hua. Clinical manifestation and gene mutation of multiple endocrine neoplasia 2A: analysis of a pedigree data [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 481-486. |
[12] | ZHANG Lipeng, WANG Zhongmin, ZHAO Xinjian. Splenic artery embolization versus surgery in treatment of traumatic splenic injury: a comparative study [J]. Journal of Surgery Concepts & Practice, 2020, 25(03): 222-226. |
[13] | ZHANG Shu, WANG Lulu, SUN Jing, JIANG Shihu. Value of procalcitonin and C-reactive protein in early stage acute biliary pancreatitis [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(06): 668-671. |
[14] | . [J]. Journal of Internal Medicine Concepts & Practice, 2019, 14(04): 225-229. |
[15] | WANG Yuanyuan, FAN Qiuling. Clinical value of serum procalcitonin in patients of chronic kidney disease with bacterial infection [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(03): 353-359. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||